Hearing Prosthetics Clause Samples
Hearing Prosthetics. The Medical Insurance provisions under the Aetna High Option or its equivalent shall provide:
1. Vision Care
2. PAP Smear
3. Major Medical coverage of hearing prosthetic expense in excess of current benefit.
4. A two-hundred dollar ($200) family deductible will be calculated on a “rolling” basis whereby all family members’ covered expenses count to- ▇▇▇▇ the family deductible. This section only summarizes unit health benefits. Complete information will be provided in a Booklet- Certificate at a later date. Effective as of the date such change can be imple- mented by CIGNA (but not earlier than September 1, 2006), a new 3-tier prescription drug program will be implemented in the CIGNA-Open Access Plus product with the basic retail pharmacy provision as follows:
1. $5 co-pay for Generic Drugs
2. $10 co-pay for Preferred Brand Name Drugs, and
3. $20 co-pay for non-Preferred Brand Name Drugs Mail order program will provide a 90-day supply for two times the 30-day retail pharmacy co-pay. This section only summarizes unit health benefits. Complete information has been provided in a Book- let-Certificate issued to employees.
Hearing Prosthetics. The Medical Insurance provisions under the Aetna High Option or its equivalent shall provide:
1. Vision Care
2. PAP Smear
3. Major Medical coverage of hearing prosthetic expense in excess of current benefit.
4. A two-hundred dollar ($200) family deductible will be calculated on a “rolling” basis whereby all family members’ covered expenses count toward the family deductible. This section only summarizes unit health benefits. Complete information will be provided in a Booklet- Certificate at a later date. Effective as of the date such change can be implemented by CIGNA (but not earlier than September 1, 2006), a new 3-tier prescription drug program will be implemented in the CIGNA-Open Access Plus product with the basic retail pharmacy provision as follows:
1. $5 co-pay for Generic Drugs
2. $10 co-pay for Preferred Brand Name Drugs, and
